|Bid||0.00 x 100|
|Ask||0.00 x 100|
|Day's Range||267.28 - 276.42|
|52 Week Range||208.48 - 287.94|
|Beta (3Y Monthly)||0.88|
|PE Ratio (TTM)||21.12|
|Earnings Date||Jan 14, 2019 - Jan 18, 2019|
|Forward Dividend & Yield||3.60 (1.34%)|
|1y Target Est||309.41|
In the latest trading session, UnitedHealth Group (UNH) closed at $276.85, marking a -0.61% move from the previous day.
All 30 components of the Dow Jones Industrial Average are losing ground in morning trade Thursday, with just three of the components accounting for more than one-third of the Dow's 490-point loss, enough to push the blue-chip barometer into negative territory for the year. The biggest drag was Boeing Co.'s , with the shares shedding 4.5%, and the $15.48 price decline subtracting about 105 points from the Dow's price. Next is UnitedHealth Group Inc. , with the shares down $7.29, or 2.6%, to shave about 49 points off the Dow; Apple Inc.'s stock was the third biggest drag, as it fell $5.06, or 2.9%, to knock about 34 points off the Dow. The Dow has now slipped 0.6% year to date, while the S&P 500 has lost 0.7% and the Nasdaq Composite has gained 2.4%.
Optum Bank, the nation’s leading provider of heath savings accounts, has enhanced its data and analytics tool to help increase health savings account (HSA) savings and provide accountholders with a better understanding of how to use their HSAs to pay for health care costs. Optum Bank’s updated Health Finance Journey uses behavioral science and advanced analytics to determine what motivates consumers to behave in certain ways. This provides employers that sponsor HSA qualifying insurance plans with unique insights that enable them to develop better targeted and personally relevant communications to help employees save more for their health care expenses and make better health care decisions.
MINNETONKA, Minn.-- -- uBundle™ enables employers to save up to 4 percent on medical premiums when combining a UnitedHealthcare medical plan with specialty benefits such as vision, dental, life, disability or supplemental health products Employers benefit from a simplified administrative experience while providing employees a more competitive benefits package Program enhances the value of Bridge2Health®, ...
NEW YORK, Dec. 04, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- Optum improves care coordination, patient engagement and total cost of care - Makes it a valued partner for health care systems worldwide SANTA CLARA, California , Dec. 4, 2018 /PRNewswire/ -- Based ...
- Optum improves care coordination, patient engagement and total cost of care - Makes it a valued partner for health care systems worldwide SANTA CLARA, Calif. , Dec. 4, 2018 /PRNewswire/ -- Based on its ...
Continuous innovation and research in the field of biotechnology and an increasingly aged population in the United States are helping whet appetite for healthcare shares.
The Zacks Analyst Blog Highlights: General Motors, Boeing, Microsoft, Merck and UnitedHealth
Pilot Launched in April under Leadership of Humana, MultiPlan, Optum, Quest Diagnostics and UnitedHealthcare
On November 29, United Health Group’s (UNH) stock price closed at $282.55, which is ~8% growth from its close of $261.62 on November 23. United Health Group’s stock price increased from $220.46 to $282.55 when the market closed on November 29, which reflects ~28% YTD (year-to-date) growth. On November 29, United Health Group hit its 52-week high of $285.45.
The Zacks Analyst Blog Highlights: Boeing, Merck, Microsoft, UnitedHealth and American Express
Tickets from multiple carriers are on sale out of Paine Field now... T-Moible's CEO is sticking around ... and other notable nuggets you may have missed this week.
In the latest trading session, UnitedHealth Group (UNH) closed at $282.55, marking a +0.57% move from the previous day.
This week the Trump administration proposed allowing Medicare Part D pharmacy drug plans to be more selective on branded drugs from what are known as the six special therapeutic classes. Executives at pharmacy benefits managers have welcomed the new proposed rules. Many expressing relief that the administration has heard what they had to say and reinforced their role in the system.
Ana Gupte, PhD., managing director and senior analyst for Leerink Partners, discusses the strong health care sector with CNBC's "Power Lunch"